MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms

[1]  K. Shirahige,et al.  DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation , 2016, Nature Communications.

[2]  R. Hills,et al.  Simpson's Paradox and the Impact of Different DNMT3A Mutations on Outcome in Younger Adults With Acute Myeloid Leukemia. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  C. Bloomfield,et al.  Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML. , 2014, Blood.

[4]  Angela G. Fleischman,et al.  Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. , 2013, The New England journal of medicine.

[5]  Roberta Spinelli,et al.  Recurrent SETBP1 mutations in atypical chronic myeloid leukemia , 2012, Nature Genetics.

[6]  L. Pasqualucci,et al.  The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations , 2012, Leukemia.

[7]  Vivek Jayaswal,et al.  miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death , 2012, Molecular Cancer.

[8]  T. Davison,et al.  miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia. , 2011, Experimental hematology.

[9]  Yong-mei Zhu,et al.  Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia , 2011, Nature Genetics.

[10]  Guido Marcucci,et al.  The prognostic and functional role of microRNAs in acute myeloid leukemia. , 2011, Blood.

[11]  R. Stallings,et al.  MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2 , 2011, Cell Death and Differentiation.

[12]  Joshua F. McMichael,et al.  DNMT3A mutations in acute myeloid leukemia. , 2010, The New England journal of medicine.

[13]  Li Ding,et al.  Complete characterization of the microRNAome in a patient with acute myeloid leukemia. , 2010, Blood.

[14]  H. Allgayer,et al.  MicroRNAs-10a and -10b Contribute to Retinoic Acid-induced Differentiation of Neuroblastoma Cells and Target the Alternative Splicing Regulatory Factor SFRS1 (SF2/ASF)* , 2010, The Journal of Biological Chemistry.

[15]  R. Stam,et al.  Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia , 2010, Haematologica.

[16]  Stefano Piccolo,et al.  MicroRNA control of signal transduction , 2010, Nature Reviews Molecular Cell Biology.

[17]  A. Lund.  miR-10 in development and cancer , 2010, Cell Death and Differentiation.

[18]  Raquel P. Ritchie,et al.  miR-10a Contributes to Retinoid Acid-induced Smooth Muscle Cell Differentiation* , 2010, The Journal of Biological Chemistry.

[19]  M. Lerch,et al.  Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. , 2009, Gastroenterology.

[20]  M. Kyba,et al.  A conserved role for Hox paralog group 4 in regulation of hematopoietic progenitors. , 2009, Stem cells and development.

[21]  Borja Saez,et al.  Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell Growth , 2008, Molecular Cancer Research.

[22]  F. Marincola,et al.  Differentiation of two types of mobilized peripheral blood stem cells by microRNA and cDNA expression analysis , 2008, Journal of Translational Medicine.

[23]  Torsten Haferlach,et al.  Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin , 2008, Proceedings of the National Academy of Sciences.

[24]  L. Ringrose,et al.  How does noncoding transcription regulate Hox genes? , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.

[25]  Peter Schirmacher,et al.  MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma , 2007, Hepatology.

[26]  R. Zini,et al.  MicroRNA expression profile in granulocytes from primary myelofibrosis patients. , 2007, Experimental hematology.

[27]  H. Auer,et al.  HOXB4's road map to stem cell expansion , 2007, Proceedings of the National Academy of Sciences.

[28]  D. Valle,et al.  DNA methylation regulates microRNA expression , 2007, Cancer biology & therapy.

[29]  C. Croce,et al.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. , 2007, JAMA.

[30]  Jason H. Moore,et al.  Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. , 2007, Cancer research.

[31]  C. Croce,et al.  CD34+ hematopoietic stem-progenitor cell microRNA expression and function: A circuit diagram of differentiation control , 2006, Proceedings of the National Academy of Sciences.

[32]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[33]  George A Calin,et al.  MicroRNA fingerprints during human megakaryocytopoiesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Michael Zuker,et al.  MicroRNA-responsive 'sensor' transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression , 2004, Nature Genetics.

[35]  R. Humphries,et al.  Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells , 1999, Leukemia.

[36]  R. Krumlauf,et al.  Initiation of Rhombomeric Hoxb4 Expression Requires Induction by Somites and a Retinoid Pathway , 1998, Neuron.